A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis progression. The biomarkers will be useful for the design and interpretation of trials of new disease modifying drugs.
A combination of biochemical and MRI markers will allow improved measurement of osteoarthritis progression. The biomarkers will be useful for the design and interpretation of trials of new disease modifying drugs.